Pseudomonas aeruginosa Adaptation to Lungs of Cystic Fibrosis Patients Leads to Lowered Resistance to Phage and Protist Enemies

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Friman, Ville Petri ^a,b,e   Ghoul, Melanie ^a   Molin, Søren ^c   Johansen, Helle Krogh ^d   Buckling, Angus ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d Rigshospitalet   (Denmark)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE;

ACANTHAMOEBA POLYPHAGA; ADAPTATION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL IMMUNITY; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIOPHAGE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE DURATION; GALLERIA MELLONELLA; HUMAN; IN VITRO STUDY; LARVAL STAGE; NONHUMAN; PROTEIN EXPRESSION; PROTIST; PSEUDOMONAS AERUGINOSA; TETRAHYMENA THERMOPHILA;

ADAPTATION, PHYSIOLOGICAL; BACTERIOPHAGES; CYSTIC FIBROSIS; HUMANS; LUNG; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; QUANTITATIVE TRAIT, HERITABLE; TETRAHYMENA; VIRULENCE;

EID: 84884373003     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075380     Document Type: Article

References (60)

1. Ehrlich PR, Raven PH, (1964) Butterflies and Plants- a Study in Coevolution. Evolution; international journal of organic evolution 18: 586-608.
2. Price PW, (1980) Evolutionary biology of parasites. Monographs in population biology 15: 1-237.
3. Thompson JN (1994) The coevolutionary process. Chicago: University of Chicago Press. xi, 376 p.p.
4. Thompson JN, (2005) Coevolution: the geographic mosaic of coevolutionary arms races. Current biology: CB 15: R992-994.
5. Moran NA, Wernegreen JJ, (2000) Lifestyle evolution in symbiotic bacteria: insights from genomics. Trends in ecology & evolution 15: 321-326.
6. Moran NA, (2002) Microbial minimalism: genome reduction in bacterial pathogens. Cell 108: 583-586.
7. Hollsing AE, Granstrom M, Vasil ML, Wretlind B, Strandvik B, (1987) Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. Journal of clinical microbiology 25: 1868-1874.
8. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, et al. (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proceedings of the National Academy of Sciences of the United States of America 103: 8487-8492.
9. Cigana C, Lore NI, Bernardini ML, Bragonzi A, (2011) Dampening Host Sensing and Avoiding Recognition in Pseudomonas aeruginosa Pneumonia. Journal of biomedicine & biotechnology 2011: 852513.
10. Mathee K, Narasimhan G, Valdes C, Qiu X, Matewish JM, et al. (2008) Dynamics of Pseudomonas aeruginosa genome evolution. Proceedings of the National Academy of Sciences of the United States of America 105: 3100-3105.
11. de Bentzmann S, Plesiat P, (2011) The Pseudomonas aeruginosa opportunistic pathogen and human infections. Environmental microbiology 13: 1655-1665.
12. Folkesson A, Jelsbak L, Yang L, Johansen HK, Ciofu O, et al. (2012) Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nature Reviews Microbiology 10: 841-851.
13. Casadevall A, Pirofski LA, (2007) Accidental virulence, cryptic pathogenesis, martians, lost hosts, and the pathogenicity of environmental microbes. Eukaryotic cell 6: 2169-2174.
14. Steinberg KM, Levin BR, (2007) Grazing protozoa and the evolution of the Escherichia coli O157:H7 Shiga toxin-encoding prophage. Proceedings Biological sciences/The Royal Society 274: 1921-1929.
15. Matz C, Kjelleberg S, (2005) Off the hook--how bacteria survive protozoan grazing. Trends in microbiology 13: 302-307.
16. Cirillo JD, Cirillo SL, Yan L, Bermudez LE, Falkow S, et al. (1999) Intracellular growth in Acanthamoeba castellanii affects monocyte entry mechanisms and enhances virulence of Legionella pneumophila. Infection and immunity 67: 4427-4434.
17. Harb OS, Gao LY, Abu Kwaik Y, (2000) From protozoa to mammalian cells: a new paradigm in the life cycle of intracellular bacterial pathogens. Environmental microbiology 2: 251-265.
18. Friman VP, Lindstedt C, Hiltunen T, Laakso J, Mappes J, (2009) Predation on multiple trophic levels shapes the evolution of pathogen virulence. PLoS One 4: e6761.
19. Brown SP, Cornforth DM, Mideo N, (2012) Evolution of virulence in opportunistic pathogens: generalism, plasticity, and control. Trends Microbiol 20: 336-342.
20. Mikonranta L, Friman VP, Laakso J, (2012) Life history trade-offs and relaxed selection can decrease bacterial virulence in environmental reservoirs. PloS one 7: e43801.
21. Kassen R, (2002) The experimental evolution of specialists, generalists, and the maintenance of diversity. Journal of evolutionary biology 15: 173-190.
22. Futuyma DJ, Moreno G, (1988) The Evolution of Ecological Specialization. Annual Review of Ecology and Systematics 19: 207-233.
23. Tan MW, (2002) Cross-species infections and their analysis. Annual Review of Microbiology 56: 539-565.
24. Jousset A, (2012) Ecological and evolutive implications of bacterial defences against predators. Environmental microbiology 14: 1830-1843.
25. Yang L, Jelsbak L, Marvig RL, Damkiaer S, Workman CT, et al. (2011) Evolutionary dynamics of bacteria in a human host environment. Proceedings of the National Academy of Sciences of the United States of America 108: 7481-7486.
26. Zaborin A, Romanowski K, Gerdes S, Holbrook C, Lepine F, et al. (2009) Red death in Caenorhabditis elegans caused by Pseudomonas aeruginosa PAO1. Proceedings of the National Academy of Sciences of the United States of America 106: 6327-6332.
27. Johansen HK, Norregaard L, Gotzsche PC, Pressler T, Koch C, et al. (2004) Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?-A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection. Pediatr Pulmonol 37: 427-432.
28. Selezska K, Kazmierczak M, Musken M, Garbe J, Schobert M, et al. (2012) Pseudomonas aeruginosa population structure revisited under environmental focus: impact of water quality and phage pressure. Environmental microbiology 14: 1952-1967.
29. Elliott AM, (1959) Biology of Tetrahymena. Annual Review of Microbiology 13: 79-96.
30. Hauer G, Rogerson A, (2005) Remarkable salinity tolerance of seven species of naked amoebae (gymnamoebae). Hydrobiologia 549: 33-42.
31. Merabishvili M, Pirnay JP, Verbeken G, Chanishvili N, Tediashvili M, et al. (2009) Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PloS one 4: e4944.
32. Pernthaler J, (2005) Predation on prokaryotes in the water column and its ecological implications. Nature reviews Microbiology 3: 537-546.
33. Jelsbak L, Johansen HK, Frost AL, Thogersen R, Thomsen LE, et al. (2007) Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun 75: 2214-2224.
34. Buckling A, Rainey PB, (2002) Antagonistic coevolution between a bacterium and a bacteriophage. Proc Biol Sci 269: 931-936.
35. O'Toole GA, Kolter R, (1998) Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Molecular microbiology 28: 449-461.
36. Miyata S, Casey M, Frank DW, Ausubel FM, Drenkard E, (2003) Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis. Infection and immunity 71: 2404-2413.
37. Jander G, Rahme LG, Ausubel FM, (2000) Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects. J Bacteriol 182: 3843-3845.
38. Labrie SJ, Samson JE, Moineau S, (2010) Bacteriophage resistance mechanisms. Nature reviews Microbiology 8: 317-327.
39. Ojeniyi B, Birchandersen A, Mansa B, Rosdahl VT, Hoiby N, (1991) Morphology of Pseudomonas-Aeruginosa Phages from the Sputum of Cystic-Fibrosis Patients and from the Phage Typing Set- an Electron-Microscopy Study. Apmis 99: 925-930.
40. Willner D, Haynes MR, Furlan M, Hanson N, Kirby B, et al. (2012) Case Studies of the Spatial Heterogeneity of DNA Viruses in the Cystic Fibrosis Lung. American Journal of Respiratory Cell and Molecular Biology 46: 127-131.
41. James CE, Fothergill JL, Kalwij H, Hall AJ, Cottell J, et al. (2012) Differential infection properties of three inducible prophages from an epidemic strain of Pseudomonas aeruginosa. Bmc Microbiology 12.
42. Buckling A, Brockhurst M, (2012) Bacteria-virus coevolution. Advances in experimental medicine and biology 751: 347-370.
43. Lopez-Pascua LC, Buckling A, (2008) Increasing productivity accelerates host-parasite coevolution. J Evol Biol 21: 853-860.
44. Faruque SM, Naser IB, Islam MJ, Faruque AS, Ghosh AN, et al. (2005) Seasonal epidemics of cholera inversely correlate with the prevalence of environmental cholera phages. Proceedings of the National Academy of Sciences of the United States of America 102: 1702-1707.
45. Bjarnsholt T, Jensen PO, Jakobsen TH, Phipps R, Nielsen AK, et al. (2010) Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients. PloS one 5: e10115.
46. Matz C, Bergfeld T, Rice SA, Kjelleberg S, (2004) Microcolonies, quorum sensing and cytotoxicity determine the survival of Pseudomonas aeruginosa biofilms exposed to protozoan grazing. Environmental microbiology 6: 218-226.
47. Riley MA, Wertz JE, (2002) Bacteriocins: evolution, ecology, and application. Annual Review of Microbiology 56: 117-137.
48. Kunert A, Losse J, Gruszin C, Huhn M, Kaendler K, et al. (2007) Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein. Journal of immunology 179: 2979-2988.
49. Malone JG, Jaeger T, Spangler C, Ritz D, Spang A, et al. (2010) YfiBNR mediates cyclic di-GMP dependent small colony variant formation and persistence in Pseudomonas aeruginosa. PLoS pathogens 6: e1000804.
50. Hosseinidoust Z, Tufenkji N, van de Ven TGM, (2013) Predation in Homogeneous and Heterogeneous Phage Environments Affects Virulence Determinants of Pseudomonas aeruginosa. Applied and environmental microbiology 79: 2862-2871.
51. Gama JA, Abby SS, Vieira-Silva S, Dionisio F, Rocha EP, (2012) Immune subversion and quorum-sensing shape the variation in infectious dose among bacterial pathogens. PLoS Pathog 8: e1002503.
52. Malone JG, Jaeger T, Spangler C, Ritz D, Spang A, et al. (2010) YfiBNR mediates cyclic di-GMP dependent small colony variant formation and persistence in Pseudomonas aeruginosa. PLoS Pathog 6: e1000804.
53. Morello E, Saussereau E, Maura D, Huerre M, Touqui L, et al. (2011) Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention. PloS one 6: e16963.
54. Debarbieux L, Leduc D, Maura D, Morello E, Criscuolo A, et al. (2010) Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections. The Journal of infectious diseases 201: 1096-1104.
55. Alemayehu D, Casey PG, McAuliffe O, Guinane CM, Martin JG, et al. (2012) Bacteriophages phiMR299-2 and phiNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. MBio 3: e00029-00012.
56. Rau MH, Marvig RL, Ehrlich GD, Molin S, Jelsbak L, (2012) Deletion and acquisition of genomic content during early stage adaptation of Pseudomonas aeruginosa to a human host environment. Environmental microbiology 14: 2200-2211.
57. Willner D, Haynes MR, Furlan M, Schmieder R, Lim YW, et al. (2012) Spatial distribution of microbial communities in the cystic fibrosis lung. The ISME journal 6: 471-474.
58. Mowat E, Paterson S, Fothergill JL, Wright EA, Ledson MJ, et al. (2011) Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am J Respir Crit Care Med 183: 1674-1679.
59. Essoh C, Blouin Y, Loukou G, Cablanmian A, Lathro S, et al. (2013) The Susceptibility of Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients to Bacteriophages. PLoS One 8: e60575.
60. Cotter PD, Ross RP, Hill C, (2013) Bacteriocins- a viable alternative to antibiotics? Nature reviews Microbiology 11: 95-105.